首页> 外文会议>International Peptide Symposium;European Peptide Symposium >Development of mu-opioid receptor ligands by using unique L-tyrosine analogues
【24h】

Development of mu-opioid receptor ligands by using unique L-tyrosine analogues

机译:使用独特的L-酪氨酸类似物的Mu-Apioid受体配体的研制

获取原文

摘要

Opioid studies revealed that the replacement of the N-terminal tyrosine in opioid peptides with 2',6'-dimethyl-L-tyrosine(Dmt)enhanced both opioid receptor binding affinity and functional bioactivity.In order to develop potent opioid ligands,it seemed prudent therefore to study the structure-activity relationship of the alkyl groups on the aromatic ring of the Tyr residue.In this study,six L-Tyr analogues containing different alkyl groups [2'-monomethyl-tyrosine(Mmt),2' -ethyl-6 -methyl-tyrosine(Emt),2' -isopropyl-6'-methyl-tyrosine(Imt),2',6'-diethyl-tyrosine(Det),2',6'-diisopropyl-tyrosine(Dit)and 2',3',6' -trimethyl-tyrosine(Tmt)],were developed and their bioactivities were evaluated by incorporation into endomorphin-2(EM-2:YPFF-NH_2).
机译:阿片类药物的研究表明,用2',6'-二甲基-1-酪氨酸(DMT)的阿片类肽替换N-末端酪氨酸增强了阿片受体的亲和力和功能性生物活性。为了开发有效的阿片类配体,它似乎 因此,谨慎地研究烷基的烷基的结构 - 活性关系在该研究中,含有不同烷基的6L-Tyr类似物[2'-单甲基酪氨酸(MMT),2' - 乙基 -6-甲基 - 酪氨酸(EMT),2' - 异丙基-6'-甲基酪氨酸(IMT),2',6'-二乙基酪氨酸(DET),2',6'-二异丙基 - 酪氨酸(DIT) 开发了2',3',6' - 甲基酪氨酸(TMT)],并通过掺入Endomorphin-2(EM-2:YPFF-NH_2)来评价它们的生物活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号